A difference in how the brain develops and works
ADHD is classified as a neurodevelopmental disorder, meaning it is rooted in differences in how the brain develops and functions.[3][10] Both the American Psychiatric Association's Diagnostic and Statistical Manual of Mental Disorders (DSM-5-TR) and the World Health Organization's International Classification of Diseases (ICD-11) recognise ADHD within this category.[10][14]
Research links ADHD to differences across distributed brain networks involved in attention, motivation, executive control and self-regulation, and the dopamine and noradrenaline systems are involved in these processes.[3][11] There is no single “ADHD brain,” however: ADHD is not adequately explained by one neurotransmitter or one brain region, and no brain scan can diagnose it.[3]
ADHD is a recognised medical condition. It is not caused by laziness, low intelligence or poor parenting, and a person with ADHD can be highly capable.[4]
More than a century of observation
Descriptions of ADHD-like behaviour appear in the medical literature well over a hundred years ago. In 1902, the British paediatrician Sir George Frederic Still delivered lectures describing children of normal intelligence who struggled to sustain attention and regulate their behaviour — what he then called a "defect of moral control."[13]
In 1937, Charles Bradley observed that stimulant medication improved behaviour and schoolwork in some children — a finding that shaped treatment for decades.[13] Through the mid-20th century the condition was studied under labels such as "minimal brain dysfunction."[13]
The American Psychiatric Association recognised it as "hyperkinetic reaction of childhood" in the DSM-II (1968) and reframed it as "attention deficit disorder" in the DSM-III (1980). Later editions adopted the modern name and the current understanding — including the recognition that ADHD can persist into adulthood — with the DSM-5 (2013) placing it firmly among the neurodevelopmental disorders.[13][10]
A condition found across childhood and adulthood
ADHD is common worldwide. In the United States, the 2024 National Survey of Children's Health found that an estimated 11.7% of children aged 3–17 — about 7.1 million, or roughly 1 in 9 — had a current ADHD diagnosis (95% confidence interval 11.1–12.2%).[20] These are parent- or caregiver-reported survey estimates, not diagnoses independently confirmed from medical records.[20]
A current diagnosis was reported for about 14.5% of boys and 8.8% of girls, and prevalence rose with age — from 3.7% of boys and 1.6% of girls aged 3–5, to 16.2% and 8.7% at ages 6–11, to 17.5% and 12.0% at ages 12–17.[20] The earlier 2022 survey had found 11.4% of children ever diagnosed and 10.5% with a current diagnosis; the estimates are close, so the difference should not be read as a confirmed rise without a formal trend analysis.[1][2]
Source: 2024 National Survey of Children's Health (NSCH), HRSA/MCHB; parent/caregiver-reported.[20]
ADHD is not only a childhood condition. A 2021 global systematic review and meta-analysis estimated that, after adjusting for the world's population structure, about 2.6% of adults have persistent ADHD (childhood-onset ADHD continuing into adulthood) and about 6.8% have symptomatic adult ADHD (a broader estimate of adults meeting symptom-based criteria) — corresponding to roughly 140 million and 366 million adults worldwide, respectively.[9] These are historical epidemiological estimates based on evidence available up to about 2020, not a current headcount of adults living with ADHD today.
ADHD in girls and women is more likely to be missed or diagnosed late. This is not because it is rare in females but because it more often presents with inattentive or internalised difficulties rather than obvious hyperactivity; because girls and women may develop coping and masking strategies that hide their struggles; and because recognition and referral have historically been biased toward the more visible, stereotypically male presentation.[15] The gap between the sexes tends to narrow in adulthood, and lived-experience research reports that late recognition can carry a real cost — years of self-criticism, low self-esteem and missed support before diagnosis.[15][16]